PROCEPT BioRobotics announces the grand opening of its state-of-the-art global corporate headquarters in San Jose, California. This expansive facility will accommodate the company’s plans for continued growth. PROCEPT manufactures the AquaBeam Robotic System, an image-guided, automated surgical robotic system dedicated to the treatment of benign prostatic hyperplasia.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PRCT:
- Procept BioRobotics receives FDA IDE to investigate Aquablation
- Procept announces first commercial Aquablation therapy procedures in Japan
- PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston
- Procept BioRobotics, NorthShore University announce milestone
- Twilio upgraded, Sealed Air downgraded: Wall Street’s top analyst calls
